Watch Ticker

Prime Medicine, Inc. Common Stock

Go to Prime Medicine, Inc. Common Stock Website

$4.16

-0.21 (-4.92%)

Live

Previous Close

$4.37

Day Range

$4.06 - $4.36

Previous Day Range

$4.135 - $4.4964

Market Cap

$776.2 million USD

Day Vol.

1.8 million

Previous Day Vol.

4.1 million

Currency

USD

Primary Exchange

Nasdaq

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Gregory Dearborn - Prime Medicine Announces Pricing of Public Offering

Prime Medicine is conducting a public offering of 38 million shares at $3.30 per share, expecting to raise approximately $125.4 million. The Cystic Fibrosis Foundation will purchase 1,818,181 shares, and the offering is expected to close on August 1, 2025.

Related tickers: PRME.

Read Full Article

Johnny Rice - Why Prime Medicine Stock Is Soaring Today

Prime Medicine, a clinical-stage biotech company, announced a new preclinical program targeting alpha-1 antitrypsin deficiency, a genetic disorder affecting lung and liver function. Investors reacted positively to the company's plans to file an Investigational New Drug Application by mid-2026, but the development risks associated with clinical-stage biotechs remain.

Related tickers: PRME.

Read Full Article

Trending Tickers

Please sign in to view